Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page shows a system revision (Revision: v3.4.2) and removal of a prior revision (v3.4.1), plus a site-wide notice about government funding status. These are administrative updates and do not modify trial content or study details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:19:30.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Notice added about government funding lapse affecting data currency; page revision updated to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T00:43:39.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added a Show glossary option and minor metadata label updates (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), and removed older terms with different capitalization/wording (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T00:13:47.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision indicator changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:47:21.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Footer/site metadata updated: Revision v3.3.3 added; HHS Vulnerability Disclosure link removed and Revision v3.3.2 removed, with no impact on study content or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:13:50.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page shows an updated revision from v3.3.1 to v3.3.2, indicating a minor update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:26:02.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.